1	delivery	devices
1	ards	and
1	using	standard
1	.	nine
1	on	currently
1	,	ventilator-free
1	ali	or
1	based	on
1	consistent	end
1	effects	.
1	in	the
1	conditions	associated
1	treatment	of
1	reporting	on
1	clinical	application
1	epoprostenol	(aepo)
1	.	this
1	aepo	were
1	in	disease
1	the	clinical
1	estimated	mortality
1	of	either
1	in	patients
1	and	aerosolized
1	an	estimated
1	(ali)	are
1	hemodynamic	effects
1	nitric	oxide
1	severity	.
1	on	changes
1	currently	available
1	devices	and
1	been	observed
1	to	use
1	observed	in
1	addition	,
2	associated	with
1	ali	.
1	benefit	with
1	the	safety
2	changes	in
2	of	inhaled
1	studies	addressing
2	,	the
1	these	therapies
1	40–50%	.
1	(ards)	and
2	or	aepo
1	.	the
1	with	ali
1	end	points
1	seven	reports
1	.	in
1	and	standard
1	acute	respiratory
1	with	an
1	examined	for
1	modes	of
1	inhaled	vasodilators
1	vasodilators	can
1	guide	to
1	oxide	(ino)
1	the	article
1	overall	benefit
1	acute	lung
1	standard	modes
1	in	survival
1	is	safe
1	relevant	studies
1	in	addition
1	ventilator-free	days
1	safety	and
1	respiratory	distress
1	either	ino
1	oxygenation	without
1	standard	delivery
1	to	the
1	determine	the
1	for	ino
1	further	studies
1	.	no
1	therapies	.
1	points	using
1	data	,
1	,	or
1	with	ards
1	of	mechanical
2	the	use
1	article	also
1	have	been
1	this	article
1	and	efficacy
1	(aepo)	in
1	trials	were
1	syndrome	(ards)
1	article	reviews
1	or	attenuation
1	of	40–50%
1	a	practicable
2	use	of
1	aepo	.
1	randomized	controlled
1	included	for
1	mortality	of
1	aerosolized	epoprostenol
1	and	acute
1	differences	have
2	in	oxygenation
1	.	based
1	ino	reporting
1	to	determine
1	practicable	guide
1	patients	with
1	are	conditions
1	can	help
2	oxygenation	.
1	studies	with
1	of	these
1	to	improve
1	application	of
1	transiently	improve
1	use	in
1	hypoxemia	associated
1	injury	(ali)
1	oxygenation	or
2	ino	or
1	also	provides
1	days	,
1	controlled	trials
1	efficacy	of
1	lung	injury
1	the	overall
1	reports	of
1	.	seven
1	survival	,
1	attenuation	in
1	help	to
1	addressing	the
1	with	consistent
1	clinical	outcomes
1	safe	to
1	were	examined
1	of	aepo
1	aepo	is
1	distress	syndrome
1	outcomes	.
1	provides	a
1	no	differences
1	are	needed
1	or	clinical
1	or	ards
1	and	ali
1	needed	to
1	the	treatment
1	ards	to
1	prospective	randomized
1	were	included
1	without	hemodynamic
1	(ino)	and
1	disease	severity
1	with	ino
1	of	life-threatening
1	.	further
1	ventilation	are
1	to	transiently
1	inhaled	nitric
1	life-threatening	hypoxemia
2	improve	oxygenation
1	for	changes
1	available	data
1	mechanical	ventilation
1	reviews	relevant
1	nine	prospective
